• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

mRNA 周转率限制了 siRNA 和 microRNA 的功效。

mRNA turnover rate limits siRNA and microRNA efficacy.

机构信息

Computational Biology Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

出版信息

Mol Syst Biol. 2010 Nov 16;6:433. doi: 10.1038/msb.2010.89.

DOI:10.1038/msb.2010.89
PMID:21081925
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3010119/
Abstract

The microRNA pathway participates in basic cellular processes and its discovery has enabled the development of si/shRNAs as powerful investigational tools and potential therapeutics. Based on a simple kinetic model of the mRNA life cycle, we hypothesized that mRNAs with high turnover rates may be more resistant to RNAi-mediated silencing. The results of a simple reporter experiment strongly supported this hypothesis. We followed this with a genome-wide scale analysis of a rich corpus of experiments, including RT-qPCR validation data for thousands of siRNAs, siRNA/microRNA overexpression data and mRNA stability data. We find that short-lived transcripts are less affected by microRNA overexpression, suggesting that microRNA target prediction would be improved if mRNA turnover rates were considered. Similarly, short-lived transcripts are more difficult to silence using siRNAs, and our results may explain why certain transcripts are inherently recalcitrant to perturbation by small RNAs.

摘要

微 RNA 通路参与基本的细胞过程,其发现使 si/shRNAs 能够作为强大的研究工具和潜在的治疗方法得以发展。基于 mRNA 生命周期的简单动力学模型,我们假设周转率高的 mRNA 可能对 RNAi 介导的沉默具有更强的抗性。一个简单的报告基因实验的结果强烈支持了这一假设。我们接着对大量实验进行了全基因组规模的分析,其中包括数千个 siRNA 的 RT-qPCR 验证数据、siRNA/miRNA 过表达数据和 mRNA 稳定性数据。我们发现,短寿命的转录本受 miRNA 过表达的影响较小,这表明如果考虑 mRNA 周转率,miRNA 靶标预测将会得到改善。同样,使用 siRNA 更难使短寿命的转录本沉默,我们的结果可能解释了为什么某些转录本本质上对小 RNA 的干扰具有抗性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccba/3010119/faa70ca8a527/msb201089-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccba/3010119/358ade9ad15a/msb201089-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccba/3010119/596bc952216c/msb201089-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccba/3010119/e9bdab7a6583/msb201089-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccba/3010119/439f9619666c/msb201089-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccba/3010119/1e602151b991/msb201089-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccba/3010119/faa70ca8a527/msb201089-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccba/3010119/358ade9ad15a/msb201089-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccba/3010119/596bc952216c/msb201089-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccba/3010119/e9bdab7a6583/msb201089-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccba/3010119/439f9619666c/msb201089-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccba/3010119/1e602151b991/msb201089-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccba/3010119/faa70ca8a527/msb201089-f6.jpg

相似文献

1
mRNA turnover rate limits siRNA and microRNA efficacy.mRNA 周转率限制了 siRNA 和 microRNA 的功效。
Mol Syst Biol. 2010 Nov 16;6:433. doi: 10.1038/msb.2010.89.
2
Target mRNA abundance dilutes microRNA and siRNA activity.靶 mRNA 丰度使 microRNA 和 siRNA 活性降低。
Mol Syst Biol. 2010 Apr 20;6:363. doi: 10.1038/msb.2010.24.
3
RNAi revised--target mRNA-dependent enhancement of gene silencing.RNAi修正——依赖靶标mRNA的基因沉默增强
Nucleic Acids Res. 2015 Dec 15;43(22):10623-32. doi: 10.1093/nar/gkv1200. Epub 2015 Nov 17.
4
MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms.微小RNA和小干扰RNA可通过类似机制抑制信使核糖核酸的表达。
Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9779-84. doi: 10.1073/pnas.1630797100. Epub 2003 Aug 5.
5
RNA interference-induced hepatotoxicity results from loss of the first synthesized isoform of microRNA-122 in mice.RNA干扰诱导的肝毒性是由于小鼠中首个合成的微小RNA - 122亚型缺失所致。
Nat Med. 2016 May;22(5):557-62. doi: 10.1038/nm.4079. Epub 2016 Apr 11.
6
Single-cell kinetics of siRNA-mediated mRNA degradation.siRNA 介导的 mRNA 降解的单细胞动力学。
Nanomedicine. 2019 Oct;21:102077. doi: 10.1016/j.nano.2019.102077. Epub 2019 Aug 8.
7
A small molecule enhances RNA interference and promotes microRNA processing.一种小分子增强RNA干扰并促进微小RNA加工。
Nat Biotechnol. 2008 Aug;26(8):933-40. doi: 10.1038/nbt.1481. Epub 2008 Jul 20.
8
Vigilance and validation: Keys to success in RNAi screening.警惕性和验证:RNAi 筛选成功的关键。
ACS Chem Biol. 2011 Jan 21;6(1):47-60. doi: 10.1021/cb100358f. Epub 2010 Dec 28.
9
MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies.靶向mRNA通过微小RNA依赖的方式定位于哺乳动物的P小体。
Nat Cell Biol. 2005 Jul;7(7):719-23. doi: 10.1038/ncb1274. Epub 2005 Jun 5.
10
Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway.有效的RNA干扰介导的基因沉默,且不干扰内源性微小RNA途径。
Nature. 2007 Oct 11;449(7163):745-7. doi: 10.1038/nature06179. Epub 2007 Sep 26.

引用本文的文献

1
Programmable RNA Nanostructures Enable Nanopore Detection of Cotranscriptionally Introduced RNA Modifications.可编程RNA纳米结构实现了对共转录引入的RNA修饰的纳米孔检测。
Nano Lett. 2025 Aug 13;25(32):12184-12192. doi: 10.1021/acs.nanolett.5c02391. Epub 2025 Aug 4.
2
RNAi in Pest Control: Critical Factors Affecting dsRNA Efficacy.害虫防治中的RNA干扰:影响双链RNA功效的关键因素
Insects. 2025 Jul 18;16(7):737. doi: 10.3390/insects16070737.
3
Systematic analysis of siRNA and mRNA features impacting fully chemically modified siRNA efficacy.

本文引用的文献

1
Evaluation of sensitivity, performance and reproducibility of microarray technology in neuronal tissue.评估微阵列技术在神经元组织中的灵敏度、性能和重现性。
Integr Comp Biol. 2003 Dec;43(6):780-5. doi: 10.1093/icb/43.6.780.
2
Mammalian microRNAs predominantly act to decrease target mRNA levels.哺乳动物的 microRNAs 主要作用是降低靶 mRNA 水平。
Nature. 2010 Aug 12;466(7308):835-40. doi: 10.1038/nature09267.
3
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology.基因和假基因 mRNA 的一种无编码依赖性功能调节肿瘤生物学。
影响完全化学修饰的小干扰RNA(siRNA)功效的siRNA和信使核糖核酸(mRNA)特征的系统分析
Nucleic Acids Res. 2025 Jun 20;53(12). doi: 10.1093/nar/gkaf479.
4
Mechanistic intracellular PK/PD modeling to inform development strategies for small interfering RNA therapeutics.用于指导小干扰RNA疗法开发策略的细胞内作用机制的药代动力学/药效学建模
Mol Ther Nucleic Acids. 2025 Mar 17;36(2):102516. doi: 10.1016/j.omtn.2025.102516. eCollection 2025 Jun 10.
5
Engineering IGF2 for Lysosome-targeting chimeras development to target drug-resistant membrane proteins in tumor therapy.工程化胰岛素样生长因子2用于开发溶酶体靶向嵌合体,以靶向肿瘤治疗中的耐药膜蛋白。
Protein Sci. 2025 Mar;34(3):e70051. doi: 10.1002/pro.70051.
6
Development, opportunities, and challenges of siRNA nucleic acid drugs.小干扰RNA核酸药物的发展、机遇与挑战
Mol Ther Nucleic Acids. 2024 Dec 21;36(1):102437. doi: 10.1016/j.omtn.2024.102437. eCollection 2025 Mar 11.
7
Challenges and Opportunities Arising from Host- Interactions to Outline Novel and Sustainable Control Strategies: The Key Role of RNA Interference.从宿主相互作用中出现的挑战和机遇概述新的和可持续的控制策略:RNA 干扰的关键作用。
Int J Mol Sci. 2024 Jun 20;25(12):6798. doi: 10.3390/ijms25126798.
8
RNAi-based drug design: considerations and future directions.基于 RNAi 的药物设计:考虑因素和未来方向。
Nat Rev Drug Discov. 2024 May;23(5):341-364. doi: 10.1038/s41573-024-00912-9. Epub 2024 Apr 3.
9
RNA interference in the era of nucleic acid therapeutics.核酸治疗时代的RNA干扰
Nat Biotechnol. 2024 Mar;42(3):394-405. doi: 10.1038/s41587-023-02105-y. Epub 2024 Feb 26.
10
Current State of Human Gene Therapy: Approved Products and Vectors.人类基因治疗的现状:获批产品与载体
Pharmaceuticals (Basel). 2023 Oct 5;16(10):1416. doi: 10.3390/ph16101416.
Nature. 2010 Jun 24;465(7301):1033-8. doi: 10.1038/nature09144.
4
Signatures of RNA binding proteins globally coupled to effective microRNA target sites.与有效的 miRNA 靶位全局耦联的 RNA 结合蛋白特征。
Genome Res. 2010 Aug;20(8):1010-9. doi: 10.1101/gr.103259.109. Epub 2010 May 27.
5
Target mRNA abundance dilutes microRNA and siRNA activity.靶 mRNA 丰度使 microRNA 和 siRNA 活性降低。
Mol Syst Biol. 2010 Apr 20;6:363. doi: 10.1038/msb.2010.24.
6
Numerical modelling of microRNA-mediated mRNA decay identifies novel mechanism of microRNA controlled mRNA downregulation.基于 miRNA 介导的 mRNA 降解的数值建模确定了 miRNA 控制 mRNA 下调的新机制。
Nucleic Acids Res. 2010 Aug;38(14):4579-85. doi: 10.1093/nar/gkq220. Epub 2010 Apr 5.
7
Discovery of microvascular miRNAs using public gene expression data: miR-145 is expressed in pericytes and is a regulator of Fli1.利用公共基因表达数据发现微小血管 microRNAs:miR-145 在周细胞中表达,是 Fli1 的调节因子。
Genome Med. 2009 Nov 16;1(11):108. doi: 10.1186/gm108.
8
Nonoptimal microbial response to antibiotics underlies suppressive drug interactions.对抗生素的非最佳微生物反应是抑制性药物相互作用的基础。
Cell. 2009 Nov 13;139(4):707-18. doi: 10.1016/j.cell.2009.10.025.
9
Concordant regulation of translation and mRNA abundance for hundreds of targets of a human microRNA.数百个人类 microRNA 靶标翻译和 mRNA 丰度的协调调节。
PLoS Biol. 2009 Nov;7(11):e1000238. doi: 10.1371/journal.pbio.1000238. Epub 2009 Nov 10.
10
Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs.小RNA的转染会全面干扰内源性微小RNA对基因的调控。
Nat Biotechnol. 2009 Jun;27(6):549-55. doi: 10.1038/nbt.1543.